Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

310 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

NCT03045120

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Mount Sinai Hospital Chicago, Illinois, United States
  • Alexian Brothers Medical Center Elk Grove Village, Illinois, United States
  • The Cancer Institute At Alexian Brothers Elk Grove Village, Illinois, United States
  • Northwest Oncology & Hematology, SC Hoffman Estates, Illinois, United States
View all 24 locations
View Trial Details
Completed

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

NCT01850004

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Local Institution - 0006 Duarte, California, United States
  • Local Institution - 0029 Los Angeles, California, United States
  • Local Institution - 0001 San Franisco, California, United States
  • Local Institution - 0013 Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

NCT00450450

Conditions
Bone Marrow Diseases, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, +29 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Childrens Memorial Hospital Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

NCT04925141

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • The Second People's Hospital of Shenzhen Shenzhen, Guangdong, China
  • Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Affiliated Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • The First Affiliated Hospital, Medical College , Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

NCT01856283

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • A.O. Ospedale S. Antonio Gallarate, Milano, Italy
  • Ospedale Desio- "Ospedale Civile" di Vimercate, Desio, Carate Brianza, Giussano, Seregno. Vimercate, Milano, Italy
  • A.O di Circolo di Busto Arsizio Busto Arsizio, Varese, Italy
  • Ospedali Riuniti Bergamo Bergamo, Italy
View all 17 locations
View Trial Details

Related conditions